CN Patent

CN111909160B — 一种乌帕替尼盐类化合物及其制备方法

Assigned to Suzhou Pengxu Pharmatech Co ltd · Expires 2024-05-28 · 2y expired

What this patent protects

本申请提供一种乌帕替尼盐类化合物及其制备方法。本申请所述方法涉及的盐制备操作简便、原料便宜易得，对乌帕替尼的纯化效果好，有利于工业化生产。

USPTO Abstract

本申请提供一种乌帕替尼盐类化合物及其制备方法。本申请所述方法涉及的盐制备操作简便、原料便宜易得，对乌帕替尼的纯化效果好，有利于工业化生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN111909160B
Jurisdiction
CN
Classification
—
Expires
2024-05-28
Drug substance claim
No
Drug product claim
No
Assignee
Suzhou Pengxu Pharmatech Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.